| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |